M&A TRANSACTION · 2025
Soleo Health acquired by Court Square Capital and WindRose Health
$1.10B· 18.3x EBITDA
Target
Soleo Health
Acquirer
Court Square Capital and WindRose Health
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
—
EBITDA
$60.0M
Deal Value
$1.10B
EV/EBITDA
18.3x
Context
This $1.10B acquisition of Soleo Health by Court Square Capital and WindRose Health sits in the pharmacy sub-vertical. The 18.3x EBITDA multiple paid in 2025 can be compared against the population median for pharmacy transactions of similar size on our Pharmacy valuation hub. Court Square Capital and WindRose Health is acquiring as a private equity buyer; see how PE acquirers typically price pharmacy businesses on our Pharmacy PE buyer-pool page.
Source
Data sourced from Press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own pharmacy
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Soleo Health acquisition.